Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,328 | 225 | 88.8% |
| Education | $345.29 | 5 | 5.8% |
| Travel and Lodging | $328.62 | 1 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endo Pharmaceuticals Inc. | $662.99 | 17 | $0 (2023) |
| PROCEPT BioRobotics Corporation | $641.00 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $547.59 | 33 | $0 (2024) |
| NeoTract Inc. | $520.73 | 5 | $0 (2020) |
| ABBVIE INC. | $494.68 | 34 | $0 (2024) |
| Boston Scientific Corporation | $467.47 | 8 | $0 (2024) |
| Coloplast Corp | $315.18 | 16 | $0 (2022) |
| Teleflex LLC | $295.42 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $173.29 | 11 | $0 (2023) |
| CONMED Corporation | $128.92 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,285 | 39 | PROCEPT BioRobotics Corporation ($619.27) |
| 2023 | $754.18 | 36 | Teleflex LLC ($145.60) |
| 2022 | $909.63 | 35 | Boston Scientific Corporation ($246.30) |
| 2021 | $714.12 | 52 | Astellas Pharma US Inc ($148.89) |
| 2020 | $665.71 | 22 | NeoTract Inc. ($259.47) |
| 2019 | $290.51 | 8 | Endo Pharmaceuticals Inc. ($226.07) |
| 2018 | $687.92 | 18 | Endo Pharmaceuticals Inc. ($139.05) |
| 2017 | $695.27 | 21 | NeoTract Inc. ($138.23) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Urology | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/14/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $149.82 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: AMS 700_URO | ||||||
| 09/25/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: AMS 700_URO | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/16/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Immunotherapy | ||||||
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/31/2024 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $14.82 | General |
| 05/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Oncology | ||||||
| 05/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Immunotherapy | ||||||
| 04/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/09/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: HORMONE REPLACEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,703 | 5,928 | $660,685 | $140,618 |
| 2022 | 39 | 2,642 | 6,444 | $657,021 | $142,387 |
| 2021 | 39 | 2,906 | 7,085 | $615,610 | $146,032 |
| 2020 | 36 | 2,448 | 5,961 | $557,986 | $134,341 |
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 549 | 693 | $172,431 | $58,584 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $44,259 | $12,246 | 27.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 190 | $39,140 | $8,900 | 22.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 61 | $77,653 | $8,477 | 10.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 252 | 297 | $21,087 | $5,335 | 25.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 79 | 86 | $54,060 | $5,039 | 9.3% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 22 | 23 | $18,974 | $4,332 | 22.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 13 | $30,030 | $4,203 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 273 | 338 | $10,799 | $2,831 | 26.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 29 | 29 | $15,517 | $2,796 | 18.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 24 | $30,903 | $2,780 | 9.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $8,523 | $2,770 | 32.5% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 18 | 23 | $9,877 | $2,456 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 42 | $8,176 | $2,380 | 29.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 546 | 654 | $16,210 | $2,218 | 13.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 20 | 20 | $7,883 | $1,580 | 20.0% |
| 86316 | Analysis for detection of tumor marker | Office | 2023 | 71 | 77 | $3,927 | $1,551 | 39.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 56 | 56 | $17,445 | $1,391 | 8.0% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 71 | 77 | $6,545 | $1,371 | 20.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 11 | 11 | $19,179 | $1,298 | 6.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 23 | 23 | $8,053 | $1,162 | 14.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 52 | 61 | $4,833 | $1,037 | 21.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 22 | $2,458 | $863.72 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,791 | $783.39 | 20.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 27 | $4,077 | $690.66 | 16.9% |
About Dr. Ben Niver, M.D
Dr. Ben Niver, M.D is a Urology healthcare provider based in Blue Ash, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1043657067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Niver, M.D has received a total of $6,002 in payments from pharmaceutical and medical device companies, with $1,285 received in 2024. These payments were reported across 231 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($5,328).
As a Medicare-enrolled provider, Niver has provided services to 10,699 Medicare beneficiaries, totaling 25,418 services with total Medicare billing of $563,378. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Blue Ash, OH
- Active Since 05/31/2013
- Last Updated 08/17/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1043657067
Products in Payments
- AQUABEAM SYSTEM (Device) $619.27
- XIAFLEX (Biological) $609.88
- BOTOX (Biological) $393.58
- UroLift (Device) $382.50
- UROLIFT (Device) $295.42
- MYRBETRIQ (Drug) $249.11
- General - Erectile Dysfunction (Device) $246.30
- Nubeqa (Drug) $173.29
- Myrbetriq (Drug) $170.50
- XTANDI (Drug) $140.31
- Urolift - UL400 (Device) $138.23
- PROVENGE (Drug) $127.64
- Axonics r-SNM System (Device) $127.44
- SpeediCath (Device) $124.84
- SPEEDICATH (Device) $121.69
- GEMTESA (Drug) $118.69
- Diclegis (Drug) $114.27
- AirSeal (Device) $111.95
- ORGOVYX (Drug) $103.10
- GENERAL - ERECTILE DYSFUNCTION (Device) $100.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Blue Ash
Mark Delworth, Md, MD
Urology — Payments: $181,185
Gary Kirsh, Md, MD
Urology — Payments: $180,723
Dr. Katherine Voss, M.d, M.D
Urology — Payments: $6,829
Patrick Wirtz, M.d, M.D
Urology — Payments: $6,245
Chandrasekar Dheenan, Md, MD
Urology — Payments: $4,193
Jeffrey Zipkin, Md, MD
Urology — Payments: $2,838